NCT05767866 2023-03-17
Assessing an Oral EGFR Inhibitor,YK-209A in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR
Suzhou Puhe Pharmaceutical Technology Co., LTD
Phase 1/2 Unknown
Suzhou Puhe Pharmaceutical Technology Co., LTD
Changhai Hospital